AAAAAA

   
Results: 1-13 |
Results: 13
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts
Authors: Blumenthal, RD Waskewich, C Goldenberg, DM Lew, W Flefleh, C Burton, J
Citation: Rd. Blumenthal et al., Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts, CLIN CANC R, 7(10), 2001, pp. 3178-3185
Response to radioimmunotherapy correlates with tumor pO(2) measured by EPRoximetry in human tumor xenografts
Authors: O'Hara, JA Blumenthal, RD Grinberg, OY Demidenko, E Grinberg, S Wilmot, CM Taylor, AM Goldenberg, DM Swartz, HM
Citation: Ja. O'Hara et al., Response to radioimmunotherapy correlates with tumor pO(2) measured by EPRoximetry in human tumor xenografts, RADIAT RES, 155(3), 2001, pp. 466-473
Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia
Authors: Blumenthal, RD Taylor, A Osorio, L Ochakovskaya, R Raleigh, JA Papadopoulou, M Bloomer, WD Goldenberg, DM
Citation: Rd. Blumenthal et al., Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia, INT J CANC, 94(4), 2001, pp. 564-571
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments
Authors: Behr, TM Blumenthal, RD Memtsoudis, S Sharkey, RM Gratz, S Becker, W Goldenberg, DM
Citation: Tm. Behr et al., Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments, CLIN CANC R, 6(12), 2000, pp. 4900-4907
Regulation of tumour drug delivery by blood flow chronobiology
Authors: Blumenthal, RD Osorio, L Ochakovskaya, R Ying, Z Goldenberg, DM
Citation: Rd. Blumenthal et al., Regulation of tumour drug delivery by blood flow chronobiology, EUR J CANC, 36(14), 2000, pp. 1876-1884
Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy
Authors: Blumenthal, RD Lew, W Reising, A Soyne, D Osorio, L Ying, ZL Goldenberg, DM
Citation: Rd. Blumenthal et al., Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy, INT J CANC, 86(2), 2000, pp. 276-280
Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy
Authors: Blumenthal, RD Lew, W Juweid, M Alisauskas, R Ying, ZL Goldenberg, DM
Citation: Rd. Blumenthal et al., Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy, CANCER, 88(2), 2000, pp. 333-343
Degranulating eosinophils in human endometriosis
Authors: Blumenthal, RD Samoszuk, M Taylor, AP Brown, G Alisauskas, R Goldenberg, DM
Citation: Rd. Blumenthal et al., Degranulating eosinophils in human endometriosis, AM J PATH, 156(5), 2000, pp. 1581-1588
Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
Authors: Behr, TM Sgouros, G Stabin, MG Behe, M Angerstein, C Blumenthal, RD Apostolidis, C Molinet, R Sharkey, RM Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S
Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
Authors: Behr, TM Salib, AL Liersch, T Behe, M Angerstein, C Blumenthal, RD Fayyazi, A Sharkey, RM Ringe, B Becker, H Wormann, B Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study, CLIN CANC R, 5(10), 1999, pp. 3232S-3242S
Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest
Authors: Juweid, ME Blumenthal, RD Lew, W Hajjar, G Rubin, AD Goldenberg, DM
Citation: Me. Juweid et al., Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest, CLIN CANC R, 5(10), 1999, pp. 3337S-3342S
Chronotolerance of experimental radioimmunotherapy: Clearance, toxicity, and maximal tolerated dose of I-131-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of dosing in a murine model
Authors: Blumenthal, RD Reising, A Lew, W Dunn, R Ying, Z Goldenberg, DM
Citation: Rd. Blumenthal et al., Chronotolerance of experimental radioimmunotherapy: Clearance, toxicity, and maximal tolerated dose of I-131-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of dosing in a murine model, EUR J CANC, 35(5), 1999, pp. 815-824
Prediction of hematologic toxicity after radioimmunotherapy with I-131-labeled anticarcinoembryonic antigen monoclonal antibodies
Authors: Juweid, ME Zhang, CH Blumenthal, RD Hajjar, G Sharkey, RM Goldenberg, DM
Citation: Me. Juweid et al., Prediction of hematologic toxicity after radioimmunotherapy with I-131-labeled anticarcinoembryonic antigen monoclonal antibodies, J NUCL MED, 40(10), 1999, pp. 1609-1616
Risultati: 1-13 |